Literature DB >> 8824275

Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain.

B E Crute1, A F Lewis, Z Wu, J H Bushweller, N A Speck.   

Abstract

The Runt domain is the DNA-binding domain defining a small family of transcription factors that are involved in important developmental processes. Developmental pathways controlled by Runt domain proteins include sex determination, neurogenesis, segmentation, and eye development in Drosophila and hematopoiesis in mammals. In addition to binding DNA, the Runt domain also mediates heterodimerization with another subunit called the core-binding factor beta (CBFbeta) subunit. In this study we overexpress the Runt domain from the mouse CBFalpha2 (AML1) protein in Escherichia coli, and purify it from the insoluble fraction. We determine the equilibrium constants for Runt domain binding to two different DNA sequences by surface plasmon resonance technology. Circular dichroism spectroscopy demonstrates that the Runt domain is a folded beta-domain with essentially no alpha-helical content. The single tryptophan residue in the CBFalpha2 Runt domain at amino acid 79 is shown by tryptophan fluorescence spectroscopy to reside in a polar environment. Finally, we demonstrate that ATP can be UV cross-linked to the Runt domain and that ATP binding is sensitive to an amino acid substitution in the putative Kinase-1a motif (P-loop).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824275     DOI: 10.1074/jbc.271.42.26251

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

2.  Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).

Authors:  T L Gu; T L Goetz; B J Graves; N A Speck
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.

Authors:  D Talibi; M Raymond
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

4.  ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.

Authors:  B Erman; M Cortes; B S Nikolajczyk; N A Speck; R Sen
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.

Authors:  S Mao; R C Frank; J Zhang; Y Miyazaki; S D Nimer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Core-binding factor influences the disease specificity of Moloney murine leukemia virus.

Authors:  A F Lewis; T Stacy; W R Green; L Taddesse-Heath; J W Hartley; N A Speck
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Making no bones about it: Transcription factors in vertebrate skeletogenesis and disease.

Authors:  Sumantra Chatterjee; V Sivakamasundari; Wenqing Jean Lee; Hsiao Yun Chan; Thomas Lufkin
Journal:  Trends Dev Biol       Date:  2012

8.  The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.

Authors:  Min-Su Han; Hyo-Jin Kim; Hee-Jun Wee; Kyung-Eun Lim; Na-Rae Park; Suk-Chul Bae; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Je-Yong Choi
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

9.  PI2PE: A Suite of Web Servers for Predictions Ranging From Protein Structure to Binding Kinetics.

Authors:  Sanbo Qin; Huan-Xiang Zhou
Journal:  Biophys Rev       Date:  2012-07-25

10.  RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.

Authors:  He-Yu Zhang; Long Jin; Gail A Stilling; Katharina H Ruebel; Kendra Coonse; Yoshinori Tanizaki; Avraham Raz; Ricardo V Lloyd
Journal:  Endocrine       Date:  2008-11-20       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.